Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 11
2021 7
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer.
Hoeltgen L, Meixner E, Hoegen P, Sandrini E, Weykamp F, Forster T, Vinsensia M, Lang K, König L, Arians N, Fremd C, Michel LL, Smetanay K, Schneeweiss A, Wallwiener M, Debus J, Hörner-Rieber J. Hoeltgen L, et al. Among authors: weykamp f. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164537. doi: 10.1177/15330338231164537. Technol Cancer Res Treat. 2023. PMID: 37038619 Free PMC article.
Preoperative Dose-Escalated Intensity-Modulated Radiotherapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial.
Seidensaal K, Dostal M, Kudak A, Jaekel C, Meixner E, Liermann J, Weykamp F, Hoegen P, Mechtersheimer G, Willis F, Schneider M, Debus J. Seidensaal K, et al. Among authors: weykamp f. Cancers (Basel). 2023 May 13;15(10):2747. doi: 10.3390/cancers15102747. Cancers (Basel). 2023. PMID: 37345084 Free PMC article.
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial.
Forster T, Köhler C, Dorn M, Häfner MF, Arians N, König L, Harrabi SB, Schlampp I, Weykamp F, Meixner E, Lang K, Heinrich V, Weidner N, Hüsing J, Wallwiener M, Golatta M, Hennigs A, Heil J, Hof H, Krug D, Debus J, Hörner-Rieber J. Forster T, et al. Among authors: weykamp f. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):857-868. doi: 10.1016/j.ijrobp.2023.05.035. Epub 2023 May 26. Int J Radiat Oncol Biol Phys. 2023. PMID: 37244626 Free article.
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N. Meixner E, et al. Among authors: weykamp f. Radiat Oncol. 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. Radiat Oncol. 2023. PMID: 36624483 Free PMC article. Clinical Trial.
Adjuvant Radiation Therapy for Male Breast Cancer-A Rare Indication?
Forster T, Köhler C, El Shafie R, Weykamp F, König L, Arians N, Adeberg S, Michel L, Smetanay K, Golatta M, Sohn C, Heil J, Schneeweiss A, Debus J, Hörner-Rieber J. Forster T, et al. Among authors: weykamp f. Cancers (Basel). 2020 Dec 4;12(12):3645. doi: 10.3390/cancers12123645. Cancers (Basel). 2020. PMID: 33291697 Free PMC article.
35 results